Bill Text: IA SF2089 | 2023-2024 | 90th General Assembly | Introduced
Bill Title: A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2024-01-25 - Subcommittee: Edler, Costello, and Jochum. S.J. 152. [SF2089 Detail]
Download: Iowa-2023-SF2089-Introduced.html
Senate
File
2089
-
Introduced
SENATE
FILE
2089
BY
BISIGNANO
A
BILL
FOR
An
Act
relating
to
ensuring
the
provision
of
accessible
1
prescription-related
measures
for
persons
who
are
2
blind,
have
a
visual
impairment,
or
otherwise
have
print
3
disabilities.
4
BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
5
TLSB
5099XS
(2)
90
pf/ko
S.F.
2089
Section
1.
NEW
SECTION
.
155A.49
Accessible
1
prescription-related
measures
for
persons
who
are
blind,
2
visually
impaired,
or
otherwise
have
print
disabilities
——
rules.
3
1.
The
board
shall
adopt
rules
pursuant
to
chapter
17A
4
to
ensure
that
no
later
than
October
31,
2024,
a
person
who
5
is
blind,
has
a
visual
impairment,
or
otherwise
has
a
print
6
disability
has
appropriate
access
to
prescription
drug
labels,
7
bag
tags,
and
medical
guides.
The
accessibility
measures
shall
8
meet
all
of
the
following
requirements:
9
a.
Be
provided
at
no
additional
cost
to
such
persons.
10
b.
Provide
information
in
a
format
that
is
fully
accessible
11
to
a
person
who
is
blind,
has
a
visual
impairment,
or
otherwise
12
has
a
print
disability.
13
c.
Provide
information
to
a
person
who
is
blind,
has
a
14
visual
impairment,
or
otherwise
has
a
print
disability
within
15
a
time
frame
comparable
to
the
time
frame
within
which
the
16
information
is
provided
to
a
person
who
is
not
blind,
does
not
17
have
a
visual
impairment,
or
does
not
otherwise
have
a
print
18
disability.
19
2.
In
adopting
rules
under
this
section,
the
board
shall
20
solicit
input
from
persons
who
are
blind,
have
a
visual
21
impairment,
or
otherwise
have
a
print
disability.
22
3.
The
rules
adopted
under
this
section
shall
meet
all
of
23
the
following
requirements:
24
a.
Comply
with
the
guidelines
and
recommendations
in
the
25
United
States
government
accountability
office
report
published
26
in
December
2016,
entitled
“Prescription
Drug
Labels:
Actions
27
Needed
to
Increase
Awareness
of
Best
Practices
for
Accessible
28
Labels
for
Individuals
Who
are
Blind
or
Visually
Impaired”.
29
b.
Include
a
method
for
providing
notice
to
the
public
30
that
accessible
prescription
drug
labels,
bag
tags,
and
31
medical
guides
are
available,
including
notice
regarding
the
32
availability
of
the
prescription
drug
labels,
bag
tags,
and
33
medical
guides
in
audio
format.
34
4.
The
board
shall
submit
a
report
to
the
governor
and
the
35
-1-
LSB
5099XS
(2)
90
pf/ko
1/
3
S.F.
2089
general
assembly
by
January
1,
2025,
which
includes
information
1
regarding
progress
in
the
implementation
of
the
rules,
2
recommendations
regarding
additional
measures
for
improving
3
accessibility,
and
projected
costs
of
implementing
enhanced
4
dispensing
fees
to
defray
the
costs
of
providing
accessible
5
prescription
drug
labels,
bag
tags,
and
medical
guides
to
6
persons
who
are
blind,
have
a
visual
impairment,
or
otherwise
7
have
a
print
disability.
8
EXPLANATION
9
The
inclusion
of
this
explanation
does
not
constitute
agreement
with
10
the
explanation’s
substance
by
the
members
of
the
general
assembly.
11
This
bill
requires
the
board
of
pharmacy
to
adopt
12
administrative
rules
no
later
than
October
31,
2024,
to
13
ensure
that
a
person
who
is
blind,
has
a
visual
impairment,
14
or
otherwise
has
a
print
disability
has
appropriate
access
to
15
prescription
drug
labels,
bag
tags,
and
medical
guides.
The
16
accessibility
measures
shall
be
provided
at
no
additional
cost
17
to
such
person,
provide
information
in
a
format
that
is
fully
18
accessible
to
a
person
who
is
blind,
has
a
visual
impairment,
19
or
otherwise
has
a
print
disability,
and
provide
information
to
20
a
person
who
is
blind,
has
a
visual
impairment,
or
otherwise
21
has
a
print
disability
within
a
time
frame
comparable
to
the
22
time
frame
within
which
the
information
is
provided
to
a
23
person
who
is
not
blind,
does
not
have
a
visual
impairment,
or
24
otherwise
does
not
have
a
print
disability.
25
The
board
is
required
to
solicit
input
in
developing
the
26
rules
from
persons
who
are
blind,
have
a
visual
impairment,
27
or
otherwise
have
a
print
disability.
The
rules
shall
comply
28
with
the
guidelines
and
recommendations
in
the
United
States
29
government
accountability
office
report
published
in
December
30
2016,
entitled
“Prescription
Drug
Labels:
Actions
Needed
to
31
Increase
Awareness
of
Best
Practices
for
Accessible
Labels
for
32
Individuals
Who
are
Blind
or
Visually
Impaired”,
and
shall
33
include
a
method
for
providing
notice
to
the
public
that
34
accessible
prescription
drug
labels,
bag
tags,
and
medical
35
-2-
LSB
5099XS
(2)
90
pf/ko
2/
3
S.F.
2089
guides
are
available.
1
The
board
shall
submit
a
report
to
the
governor
and
the
2
general
assembly
by
January
1,
2025,
which
includes
information
3
regarding
progress
in
the
implementation
of
the
rules,
4
recommendations
regarding
additional
measures
for
improving
5
accessibility,
and
projected
costs
of
implementing
enhanced
6
dispensing
fees
to
defray
the
costs
of
providing
accessible
7
prescription
drug
labels,
bag
tags,
and
medical
guides
to
8
persons
who
are
blind,
have
a
visual
impairment,
or
otherwise
9
have
a
print
disability.
10
-3-
LSB
5099XS
(2)
90
pf/ko
3/
3
